BTA biota holdings limited

a good read today and factual, page-8

  1. 4,672 Posts.
    lightbulb Created with Sketch. 16
    The Australian article on BTA was very informative regarding the history of developing Relenza but it won't do anything for the share price which will struggle to get back over $2.20. It is way overvalued and the company is still reluctant to discuss the financial benefits they will gain from increased Relenz sales. It is quite clear that they do not want to improve financial transparency as they know the current Market Cap cannot be justified by fundamentals.

    Coop
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.